J. Meijs's Profile

Role	Title	Level	Year	L/R
🐜	Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies 11 auth. I. Markusse, J. Meijs, B. de Boer, J. Bakker, H. Pascal C. Schippers, A. Schouffoer, ... N. Ajmone Marsan, L. Kroft, M. Ninaber, T. Huizinga, J. D. de Vries-Bouwstra	6	2016	6 🐜
🐬	External validation of the revised Baux score for the prediction of mortality in patients with acute burn injury J. Dokter, J. Meijs, I. Oen, M. V. van Baar, C. H. van der Vlies, H. Boxma	5	2014	5 🐬
🐜	Rituximab in early systemic sclerosis 11 auth. M. Boonstra, J. Meijs, A. Dorjée, N. Marsan, A. Schouffoer, M. Ninaber, ... K. Quint, F. Bonte‐Mineur, T. Huizinga, H. Scherer, J. D. de Vries-Bouwstra	5	2017	5 🐜
🦁	Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis 9 auth. J. Meijs, A. Schouffoer, N. Ajmone Marsan, L. Kroft, T. Stijnen, M. Ninaber, ... T. Huizinga, T. V. Vliet Vlieland, J. D. de Vries-Bouwstra	5	2016	5 🦁
🐢	‘Welzijn op Recept’ (Social Prescribing): a helping hand in re-establishing social contacts – an explorative qualitative study M. Heijnders, J. Meijs	4	2017	4 🐢
🦁	Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan. J. Meijs, A. Voskuyl, J. Bloemsaat-Minekus, M. Vonk	4	2015	4 🦁
🦁	Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch. J. Meijs, D. Pors, T. V. Vliet Vlieland, T. Huizinga, A. Schouffoer	4	2014	4 🦁
🦁	Health-care utilization in Dutch systemic sclerosis patients 9 auth. J. Meijs, E. Zirkzee, A. Schouffoer, S. Henquet, M. Caljouw, T. Stijnen, ... T. Huizinga, A. Schuerwegh, T. V. Vliet Vlieland	3	2014	3 🦁